The role of carboxy-terminal glycosaminoglycan-binding domain of vitronectin in cytoskeletal organization and migration of endothelial cells

Cell Communication and Adhesion

Volumn 4, Issue 4-5, 1996, Pages 317-325

  Thiagarajan, Perumal ^a   Le, Anhquyen ^a   Snuggs, Mark B ^a   Vanwinkle, Barry ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Cell adhesion; Cytoskeletal organization; Vitronectin

Indexed keywords

CARBOHYDRATE BINDING PROTEIN; FORMIC ACID; GLUTATHIONE TRANSFERASE; GLYCOSAMINOGLYCAN; HYBRID PROTEIN; VITRONECTIN;

ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; CELL MIGRATION; CHEMOTAXIS; CONSENSUS SEQUENCE; CONTROLLED STUDY; CYTOSKELETON; ENDOTHELIUM CELL; ESCHERICHIA COLI; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; STRUCTURE ACTIVITY RELATION;

CELL ADHESION; CELL MOVEMENT; CELLS, CULTURED; CYTOSKELETON; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; GLYCOSAMINOGLYCANS; HUMANS; PEPTIDE FRAGMENTS; RECOMBINANT FUSION PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; UMBILICAL VEINS; VITRONECTIN;

EID: 0030464565     PISSN: 10615385     EISSN: None     Source Type: Journal    
DOI: 10.3109/15419069609010775     Document Type: Article

References (36)

1. Honn KV and Tang DG. (1992) Adhesion molecules and tumor cell interaction with subendothelium and subendothelial matrix. Cancer and Metastasis Reviews. 11:353-75
2. Barnes DW, Silnutzer J, See C, Shaffer M. (1983). Characterization of human serum spreading factor with monoclonal antibody. Proc Natl Acad Sci USA 80:1362-66.
3. Hayman EG, Pierschbacher MD, Ohgren Y, Ruoslahti E. (1983). Serum spreading factor (vitronectin) is present at the cell surface and in tissues. Proc Natl Acad Sci USA 80:4003-7
4. Suzuki S, Oldberg A, Hayman EG, Pierschbacher MD, Ruoslahti E. (1985). Complete amino acid sequence of human vitronectin deduced from cDNA. Similarity of cell attachment sites in vitronectin and fibronectin. EMBO J 4.2519-24.
5. Jenne D and Stanley K K: (1985) Molecular cloning of S-protein, a link between complement, coagulation and cell substrate adhesion EMBO BO 4:391-395.
6. Pytela R, Pierschbacher MD, Ginsberg MH, Plow EF and Ruoslahti E: (1986). Platelet membrane protein IIB-IIIa. Member of a family of Arg-Gly-Asp-specific adhesion receptors Science 231:1559-1561.
7. Charo IF, Bekeart LS, Phillips DR. (1987). The platelet glycoprotein IIb-IIIa-like proteins mediate endothelial cell attachment to adhesive proteins and extracellular matrix. J Biol Chem 262:9935-38.
8. Bodary SC, McLean JW. The integrin β1 submit associates with the vitronectin receptor αV submit to form a novel vitronectin receptor in a human embryonic kidney cell line. J Biol Chem 265:5938-41.
9. Chen CS, Thiagarajan P Schwartz SM, Harlan JM and Heimark RL. (1987). The platelet glycoprotein IIb/IIIa-like protein in human endothelial cells promotes adhesion but not initial attachment to extracellular matrix J Cell Biol 105:1885-92.
10. Guettier C, Hinglais N, Bruneval P, Kazatchkine M, Bariety J, Camillen JP (1989). Immunohistochemical localization of S protein/vitronectin in human atherosclerotic versus arteriosclerotic arteries. Virchows Arch 414:309-313.
11. Sato R, Komine Y, Imanka T, Takano T. 1990. Monoclonal antibody EMR1a/212D recognizing site of deposition of extracellular lipid in atherosclerosis. Isolation and characterization of the cDNA clone for that antigen. J Bio Chem 265:21232-6
12. Declerck PJ, De Mol M, Alessi M-C, Baudner S, Paques E-P, Preissner KT, Muller-Berghaus G, Collen D. (1988). Purification and characterization of a plasminogen activator inhibitor 1 binding protein from human plasma: Identification as a multimeric form of S protein (Vitronectin). J Biol Chem 263:15454-61.
13. Wiman B, Almquist A, Siguardorttir O, Lindahl T (1988). Plasminogen activator inhibitor is bound to vitronectin in plasma. FEBS Lett 242:125-8.
14. Preissner KT, Muller-Berghaus G. (1987). Neutralization and binding of heparin by S-protein/vitronectin in the inhibition of factor Xa by antithrombin III: Involvement of an inducible heparin-binding domain of S protein/vitronectin. J Biol Chem 262:12247-53.
15. Barnes DW, Reing JE, Amos B. (1985). Heparin-binding properties of human serum spreading factor. J Biol Chem 260:9117-22.
16. Tomasini BR, Mosher DF. (1987). The identity of vitronectin and S protein. Immunological cross reactivity and functional studies. Blood 68:737-42.
17. Kost C, Stuber W, Ehrlich HJ, Pannekoek H and Preissner KT (1992). Mapping of binding sites for heparin, plasminogen activator-1 and vitronectin heparin binding domain. J Biol Chem 267:12098-105.
18. Thronton SC, Mueller SN, Levine EM (1983) Human endothelial cells: use of heparin in cloning and long-term serial cultivation. Science (Wash.DC) 227:680-681.
19. Yatohgo T, Izumi M, Kashiwagi H, Hayashi M. Novel purification of vitronectin from plasma by heparin affinity chromatography. Cell structure and function (1988). 13:281-292.
20. Landon M. (1977). Cleavage of aspartyl-prolyl bonds. Methods in Enzymol 47.145-47.
21. Suzuki S, Pierschbacher MD, Hayman EG, Nguyen K, Ohgren Y, Ruoslahti E (1984). Domain structure of vitronectin: Alignment of active sites. J Biol Chem 259.15307-147
22. Cherny RC, Honan MA, Thiagarajan, P. Site-directed mutagenesis of Arginine-Glycine Aspartic acid in vitronectin abolishes cell adhesion. J Biol Chem 268:9725-29.
23. Frangioni JV and Neel-Benjamin BG: Solubilization and purification of enzymatically active glutathione S-transferase (pGEX) fusion proteins. Analytical Biochemistry 210:179-187, (1993)
24. VanWinkle WB, Snuggs M. and Buja LM. (1994) Cytoskeletal alterations in cultured cardiomyocytes following exposure to the lipid peroxidation product, 4-hydroxynonenal. Cell Motil Cytoskel. 28:119-134.
25. Brown SL, Lundgren CH, Nordt T, Fujii S. (1994). Stimulation of migration human aortic smooth muscle cells by vitronectin: Implication for atherosclerosis Cardiovascular Research. 28:1815-20.
26. Gottheb, AI, Langille BL, Wong MKK, and Kim DW. (1991). Biology of disease: Structure and function of the endothelial cytoskeleton Lab. Invest. 65:123-137.
27. Burridge K, Path K, Kelly T, Nuckolls G, Turner C (1988). Focal Adhesions. Annu Rev Cell Biol 4:487-525
28. Madri, JA, and Williams, SK (1983). Capillary endothelial cell cultures: Phenotypic modulation by matrix components. J Cell Biology 97:153-165.
29. Woods A, Couchman JR, Johansson S, Hook M (1986). Adhesion and cytoskeletal reorganization of fibroblasts in response to fibronectin fragments. EMBO J 5:665-70.
30. Izzard CS, Radinsky R, Culp LA. (1986). Substratum contracts and cytoskeletal reorganization of Balb/c 3T3 cells on a cell-binding fragment and heparin-binding fragments of plasma fibronectin Exp Cell Res 165:320-336.
31. Woods A, Hook M, Kjellen L, Smith CG, Rees DA. (1984). Relationship of heparan sulfate proteoglycans to the cytoskeleton and extracellular matrix of cultured fibroblasts. J Cell biol 99:1743-
32. VanWinkle, W.B., Snuugs, M., and Buja, L.M. (1995). Hypoxia-induced alterations in cytoskeleton coincide with collagenase and expression in cultured neonatal cardiomyocytes. J. Mol. Cell Cardiol. 27:2531-2542.
33. Wang N, Butler JP, Ingber DE (1993). Mechanotransduction across the cell surface and through the cytoskeleton Science. 260:1124-1127
34. Lee GM, Johnstone B, Jacobson K, Caterson B (1993). The dynamic structure of pericellular matrix on living cells. J Cell Biology 123:1899-1907.
35. Sockmann A, Hess S, Declerck P, Timpl R, Preissner KT. (1993) Multimeric vitronectin. Identification and characterization of conformation-dependent self-association of the adhesive protein. J Biol Chem 268:22874-82.
36. Yeo TK, Brown L and Dvorak HF (1991). Alteration in proteoglycan synthesis common to healing wounds and tumors. Am J Pathol 138:1437-50.